Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 5/2012

Open Access 01-10-2012 | Research

Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? a meta-analysis

Authors: Yi Yun Lin, Bin He, Jian Chen, Zhi Nong Wang

Published in: Critical Care | Issue 5/2012

Login to get access

Abstract

Introduction

The aim of this study was to explore the use of dexmedetomidine as a safe and efficacious sedative agent in post-cardiac surgery patients.

Methods

A systematic literature search of MEDLINE, EMBASE, the Cochrane Library and Science Citation Index until January 2012 and review of studies was conducted. Eligible studies were of randomized controlled trials or cohort studies, comparing dexmedetomidine with a placebo or an alternative sedative agent in elective cardiac surgery, using dexmedetomidine for postoperative sedation and available in full text. Two reviewers independently performed study selection, quality assessment, and data extraction.

Results

The search identified 530 potentially relevant publications; 11 met selection criteria in this meta-analysis. Our results revealed that dexmedetomidine was associated with a shorter length of mechanical ventilation (mean difference -2.70 [-5.05, -0.35]), a lower risk of delirium (risk ratio 0.36 [0.21, 0.64]), ventricular tachycardia (risk ratio 0.27 [0.08, 0.97]) and hyperglycemia (risk ratio 0.78 [0.61, 0.99]), but may increase the risk of bradycardia (risk ratio 2.08 [1.16, 3.74]). But there was no significant difference in ICU stay, hospital stay, and morphine equivalents between the included studies. Dexmedetomidine may not increase the risk of hypotension, atrial fibrillation, postoperative nausea and vomiting, reintubation within 5 days, cardiovascular complications, postoperative infection or hospital mortality.

Conclusions

Dexmedetomidine was associated with shorter length of mechanical ventilation and lower risk of delirium following cardiac surgery. Although the risk of bradycardia was significantly higher compared with traditional sedatives, it may not increase length of hospital stay and hospital mortality. Moreover, dexmedetomidine may decrease the risk of ventricular tachycardia and hyperglycemia. Thus, dexmedetomidine could be a safe and efficacious sedative agent in cardiac surgical patients.
Appendix
Available only for authorised users
Literature
1.
Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ: Sedation in the intensive care unit: a systematic review. JAMA 2000, 283: 1451-1459. 10.1001/jama.283.11.1451CrossRefPubMed
2.
Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, Shintani AK, Thompson JL, Jackson JC, Deppen SA, Stiles RA, Dittus RS, Bernard GR, Ely EW: Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007, 298: 2644-2653. 10.1001/jama.298.22.2644CrossRefPubMed
3.
Jackson DL, Proudfoot CW, Cann KF, Walsh T: A systematic review of the impact of sedation practice in the ICU on resource use, costs and patient safety. Crit Care 2010, 14: R59. 10.1186/cc8956PubMedCentralCrossRefPubMed
4.
Hoy SM, Keating GM: Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation. Drugs 2011, 71: 1481-1501. 10.2165/11207190-000000000-00000CrossRefPubMed
5.
Christensen A: Update on dexmedetomidine for adult ICU sedation. Conn Med 2009, 73: 469-472.PubMed
6.
7.
Wijeysundera DN, Bender JS, Beattie WS: Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery. Cochrane Database Syst Rev 2009, CD004126.
8.
Wunsch H, Kahn JM, Kramer AA, Rubenfeld GD: Use of intravenous infusion sedation among mechanically ventilated patients in the United States. Crit Care Med 2009, 37: 3031-3039. 10.1097/CCM.0b013e3181b02effCrossRefPubMed
9.
Tobias JD: Dexmedetomidine and ketamine: An effective alternative for procedural sedation? Pediatr Crit Care Med 2011.
10.
Tan JA, Ho KM: Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intensive Care Med 2010, 36: 926-939. 10.1007/s00134-010-1877-6CrossRefPubMed
11.
Abd Aziz N, Chue MC, Yong CY, Hassan Y, Awaisu A, Hassan J, Kamarulzaman MH: Efficacy and safety of dexmedetomidine versus morphine in post-operative cardiac surgery patients. Int J Clin Pharm 2011, 33: 150-154. 10.1007/s11096-011-9480-7CrossRefPubMed
12.
Barletta JF, Miedema SL, Wiseman D, Heiser JC, McAllen KJ: Impact of dexmedetomidine on analgesic requirements in patients after cardiac surgery in a fast-track recovery room setting. Pharmacotherapy 2009, 29: 1427-1432. 10.1592/phco.29.12.1427CrossRefPubMed
13.
Reichert MG, Jones WA, Royster RL, Slaughter TF, Kon ND, Kincaid EH: Effect of a dexmedetomidine substitution during a nationwide propofol shortage in patients undergoing coronary artery bypass graft surgery. Pharmacotherapy 2011, 31: 673-677. 10.1592/phco.31.7.673CrossRefPubMed
14.
Herr DL, Sum-Ping ST, England M: ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth 2003, 17: 576-584. 10.1016/S1053-0770(03)00200-3CrossRefPubMed
15.
Anger KE, Szumita PM, Baroletti SA, Labreche MJ, Fanikos J: Evaluation of dexmedetomidine versus propofol-based sedation therapy in mechanically ventilated cardiac surgery patients at a tertiary academic medical center. Crit Pathw Cardiol 2010, 9: 221-226. 10.1097/HPC.0b013e3181f4ec4aCrossRefPubMed
16.
Maldonado JR, Wysong A, van der Starre PJ, Block T, Miller C, Reitz BA: Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics 2009, 50: 206-217. 10.1176/appi.psy.50.3.206CrossRefPubMed
17.
Wunsch H, Kahn JM, Kramer AA, Wagener G, Li G, Sladen RN, Rubenfeld GD: Dexmedetomidine in the care of critically ill patients from 2001 to 2007: an observational cohort study. Anesthesiology 2010, 113: 386-394. 10.1097/ALN.0b013e3181e74116CrossRefPubMed
18.
Corbett SM, Rebuck JA, Greene CM, Callas PW, Neale BW, Healey MA, Leavitt BJ: Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Crit Care Med 2005, 33: 940-945. 10.1097/01.CCM.0000162565.18193.E5CrossRefPubMed
19.
Yapici N, Coruh T, Kehlibar T, Yapici F, Tarhan A, Can Y, Ozler A, Aykac Z: Dexmedetomidine in cardiac surgery patients who fail extubation and present with a delirium state. Heart Surg Forum 2011, 14: E93-98. 10.1532/HSF98.201011102CrossRefPubMed
20.
Shehabi Y, Grant P, Wolfenden H, Hammond N, Bass F, Campbell M, Chen J: Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study). Anesthesiology 2009, 111: 1075-1084. 10.1097/ALN.0b013e3181b6a783CrossRefPubMed
21.
Dasta JF, Jacobi J, Sesti AM, McLaughlin TP: Addition of dexmedetomidine to standard sedation regimens after cardiac surgery: an outcomes analysis. Pharmacotherapy 2006,26(6):798-805. 10.1592/phco.26.6.798CrossRefPubMed
22.
23.
Rathier MO, Baker WL: A review of recent clinical trials and guidelines on the prevention and management of delirium in hospitalized older patients. Hosp Pract (Minneap) 2011, 39: 96-106. 10.3810/hp.2011.10.928CrossRef
24.
Szumita PM, Baroletti SA, Anger KE, Wechsler ME: Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am J Health Syst Pharm 2007, 64: 37-44. 10.2146/ajhp050508CrossRefPubMed
25.
Afonso J, Reis F: Dexmedetomidine: current role in anesthesia and intensive care. Rev Bras Anestesiol 2012, 62: 118-133.CrossRefPubMed
26.
Muntazar M, Kumar FC: Cardiac arrest, a preventable yet a possible risk of dexmedetomidine: fact or fiction? Anesthesiology 2004, 101: 1478-1479. author reply 1479-1480CrossRefPubMed
27.
Ingersoll-Weng E, Manecke GR Jr, Thistlethwaite PA: Dexmedetomidine and cardiac arrest. Anesthesiology 2004, 100: 738-739. 10.1097/00000542-200403000-00040CrossRefPubMed
28.
Bharati S, Pal A, Biswas C, Biswas R: Incidence of cardiac arrest increases with the indiscriminate use of dexmedetomidine: a case series and review of published case reports. Acta Anaesthesiol Taiwan 2011, 49: 165-167. 10.1016/j.aat.2011.11.010CrossRefPubMed
29.
Hammer GB, Drover DR, Cao H, Jackson E, Williams GD, Ramamoorthy C, Van Hare GF, Niksch A, Dubin AM: The effects of dexmedetomidine on cardiac electrophysiology in children. Anesth Analg 2008, 106: 79-83. 10.1213/01.ane.0000297421.92857.4eCrossRefPubMed
30.
Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ: Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000, 90: 699-705. 10.1097/00000539-200003000-00035CrossRefPubMed
31.
Martin E, Ramsay G, Mantz J, Sum-Ping ST: The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med 2003, 18: 29-41. 10.1177/0885066602239122CrossRefPubMed
32.
Venn M, Newman J, Grounds M: A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med 2003, 29: 201-207.PubMed
33.
Haga KK, McClymont KL, Clarke S, Grounds RS, Ng KY, Glyde DW, Loveless RJ, Carter GH, Alston RP: The effect of tight glycaemic control, during and after cardiac surgery, on patient mortality and morbidity: A systematic review and meta-analysis. J Cardiothorac Surg 2011, 6: 3. 10.1186/1749-8090-6-3PubMedCentralCrossRefPubMed
34.
Szekely A, Levin J, Miao Y, Tudor IC, Vuylsteke A, Ofner P, Mangano DT: Impact of hyperglycemia on perioperative mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2011, 142: 430-437. e431 10.1016/j.jtcvs.2011.03.009CrossRefPubMed
Metadata
Title
Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? a meta-analysis
Authors
Yi Yun Lin
Bin He
Jian Chen
Zhi Nong Wang
Publication date
01-10-2012
Publisher
BioMed Central
Published in
Critical Care / Issue 5/2012
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc11646

Other articles of this Issue 5/2012

Critical Care 5/2012 Go to the issue

Research

Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis

Research

Eliminating or blocking 12/15-lipoxygenase reduces neutrophil recruitment in mouse models of acute lung injury

Research

Toll-like receptors expression and interferon-γ production by NK cells in human sepsis

Commentary

Validating scores: a good business for a trauma register

Commentary

A lipid mediator controls neutrophil recruitment in acute lung injury - should we really be surprised?

Research

The relationship between serum sodium and intracranial pressure when using hypertonic saline to target mild hypernatremia in patients with head trauma